Literature DB >> 7887514

Characterization of an Actinobacillus pleuropneumoniae seeder pig challenge-exposure model.

K F Lechtenberg1, T R Shryock, G Moore.   

Abstract

Five strains of Actinobacillus pleuropneumoniae serotype 1 were used to intranasally infect 5 groups of pigs. Using each bacterial strain, infected pigs (termed seeder pigs) were commingled for 48 hours with 5 groups of noninfected test pigs, then were removed. Seeder and test pigs were maintained in isolation and were observed for 14 days. Seeder pigs had mortality that was threefold greater than that of test pigs (24% vs 8%). Rectal temperature in excess of 40.3 C was achieved for 84% of test pigs and 88% of seeder pigs. Neither of these 2 variables was statistically different between the 2 groups of pigs. Clinical impression scores > or = 2 (on a 0 to 3 scale) were three-fold (64% vs 20%) greater for seeder than for test pigs (P < 0.05). The total number of bacterial isolations or nonrecoverable isolates was tabulated for test and seeder pigs' lungs at necropsy, irrespective of the amount of lesions. The number of A pleuropneumoniae isolations was not statistically different between test and seeder pig populations. Recovery of Pasteurella multocida or other bacteria was greater from the seeder pigs (P < 0.05), whereas the number of non-recoverable isolates was greater from test pigs than from seeder pigs (P < 0.05). Assessment of lung lesions at necropsy by either visual estimation or on a weight basis were in agreement.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7887514

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  9 in total

1.  Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.

Authors:  Alexander Maas; Ilse D Jacobsen; Jochen Meens; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin.

Authors:  André G Buret
Journal:  Can J Vet Res       Date:  2010-01       Impact factor: 1.310

3.  Experimental aerosol transmission of Actinobacillus pleuropneumoniae to pigs.

Authors:  J L Jobert; C Savoye; R Cariolet; M Kobisch; F Madec
Journal:  Can J Vet Res       Date:  2000-01       Impact factor: 1.310

4.  Isolation of an atypical strain of Actinobacillus pleuropneumoniae serotype 1 with a truncated lipopolysaccharide outer core and no O-antigen.

Authors:  Mario Jacques; Josée Labrie; Frank St Michael; Andrew D Cox; Marie-Anne Paradis; C Paul Dick; Christian Klopfenstein; André Broes; Nahuel Fittipaldi; Marcelo Gottschalk
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Assessment of the efficacy of tilmicosin phosphate to eliminate Actinobacillus pleuropneumoniae from carrier pigs.

Authors:  N Fittipaldi; C Klopfenstein; M Gottschalk; A Broes; M A Paradis; C P Dick
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

6.  Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine.

Authors:  Marie-Anne Paradis; Gordon H Vessie; John K Merrill; C Paul Dick; Camille Moore; George Charbonneau; M Gottschalk; Janet I MacInnes; Robert Higgins; K R Mittal; C Girard; Jeffery J Aramini; Jeffrey B Wilson
Journal:  Can J Vet Res       Date:  2004-01       Impact factor: 1.310

Review 7.  Review of the speculative role of co-infections in Streptococcus suis-associated diseases in pigs.

Authors:  Milan R Obradovic; Mariela Segura; Joaquim Segalés; Marcelo Gottschalk
Journal:  Vet Res       Date:  2021-03-20       Impact factor: 3.683

8.  Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.

Authors:  Julien Gouré; Wendy A Findlay; Vincent Deslandes; Anne Bouevitch; Simon J Foote; Janet I MacInnes; James W Coulton; John H E Nash; Mario Jacques
Journal:  BMC Genomics       Date:  2009-02-24       Impact factor: 3.969

9.  Comparison of four lung scoring systems for the assessment of the pathological outcomes derived from Actinobacillus pleuropneumoniae experimental infections.

Authors:  Marina Sibila; Virginia Aragón; Lorenzo Fraile; Joaquim Segalés
Journal:  BMC Vet Res       Date:  2014-07-19       Impact factor: 2.741

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.